Insulin comes in several types, each designed to work at a different speed and last for a different length of time. The main categories are rapid-acting, short-acting, intermediate-acting, long-acting, and premixed combinations. Your doctor chooses between them based on when your blood sugar tends to spike, how your body responds, and whether you need steady background coverage, mealtime coverage, or both.
Rapid-Acting Insulin
Rapid-acting insulin is the fastest option available by injection. It starts working in about 15 minutes, peaks around 1 hour, and wears off within 2 to 4 hours. You take it right before or just after starting a meal to handle the blood sugar spike that food causes. The most common rapid-acting insulins are lispro, aspart, and glulisine.
Newer “ultra-rapid” versions of lispro and aspart have been developed to absorb a few minutes faster than the originals. These are designed to more closely match the way a healthy pancreas releases insulin the moment food arrives. The practical difference is small, but for some people, especially those using insulin pumps, those extra minutes of speed can help prevent post-meal blood sugar spikes.
Short-Acting (Regular) Insulin
Regular insulin, sometimes called short-acting insulin, is the oldest form still in wide use. It takes about 30 minutes to start working, peaks between 2 and 4 hours, and lasts roughly 6 to 8 hours. Because of that slower start, you typically need to inject it 30 minutes before eating rather than right at the table.
Regular insulin also comes in a high-concentration version (U-500), which packs five times more insulin per milliliter than standard U-100. This formulation exists specifically for people with severe insulin resistance who need very large daily doses. Injecting the same dose in standard concentration would require uncomfortably large volumes of fluid, so the concentrated form makes those injections practical.
Intermediate-Acting Insulin (NPH)
NPH insulin fills the gap between mealtime and all-day coverage. It has an onset of about 2 hours, a broad peak window between 4 and 12 hours, and a total duration of 18 to 26 hours. That wide peak means blood sugar lowering isn’t perfectly even throughout the day, which is why NPH is usually injected once or twice daily and often paired with a rapid-acting insulin at meals.
NPH looks cloudy in the vial and needs to be gently rolled between your hands before injection to mix it evenly. This is different from the clear appearance of rapid-acting and long-acting insulins, and it’s an important step. Skipping the mixing can lead to inconsistent doses.
Long-Acting (Basal) Insulin
Long-acting insulins provide a steady, low level of background insulin that mimics what a healthy pancreas releases between meals and overnight. The goal is to keep blood sugar from drifting upward when you’re not eating. Glargine and detemir are the most widely used options, and degludec is a newer ultra-long-acting formulation.
Glargine (in its standard U-100 form) lasts about 24 hours with minimal peak, making it a once-daily injection for most people. A more concentrated version, glargine U-300, releases even more gradually and can provide slightly longer coverage. Detemir typically lasts 12 to 24 hours and sometimes requires two injections per day. Degludec lasts over 42 hours, which provides more flexibility in injection timing. If you’re an hour or two late with your dose, the overlap from the previous injection helps prevent gaps in coverage.
Once-Weekly Insulin
The FDA has approved a once-weekly basal insulin called icodec for adults with type 2 diabetes. In clinical trials involving over 2,600 adults, people taking icodec saw their average blood sugar (measured by A1C) drop from 8.50% to 6.93% over 52 weeks, compared with a drop to 7.12% in those taking daily glargine. That improvement held steady through 78 weeks of follow-up.
Icodec is not currently approved for type 1 diabetes or for children and adolescents, though trial data has shown it performs comparably to daily degludec in type 1 diabetes. For people who struggle with daily injections, a weekly option could make a meaningful difference in consistency.
Premixed Insulin
Premixed insulins combine two types in a single vial or pen: one component handles mealtime spikes, and the other provides longer background coverage. Common ratios include 70/30 (70% intermediate-acting, 30% rapid or short-acting) and 75/25 or 50/50 blends. The ratio tells you how much of each type is in the mix.
The convenience of premixed insulin is that you take fewer injections per day, which can simplify your routine. The tradeoff is less flexibility. You can’t independently adjust the mealtime and background doses, so if your blood sugar pattern changes, you have fewer options for fine-tuning. Premixed insulins work best for people who eat on a consistent schedule and whose insulin needs are relatively stable.
Inhaled Insulin
Afrezza is a rapid-acting insulin you breathe in through a small inhaler rather than injecting. It reaches peak blood levels within 12 to 15 minutes of inhalation and clears the system in about 3 hours, making it a mealtime option. For people with type 1 diabetes, it still needs to be paired with a long-acting injectable insulin for background coverage.
Inhaled insulin isn’t an option for everyone. It’s contraindicated in people with chronic lung diseases like asthma or COPD because it can trigger sudden airway constriction. Before starting it, you’ll need lung function testing. It’s also not recommended for current smokers or people who recently quit. For those who qualify, though, it offers a needle-free way to cover meals.
Biosimilar Insulins
Biosimilar insulins are near-identical copies of brand-name insulins, similar to how generic drugs work for non-biological medications. The difference is that insulin is a large, complex molecule made from living cells, so biosimilars aren’t exact duplicates. They go through rigorous testing to confirm they work the same way in the body.
The FDA has approved biosimilar versions of glargine, and at least one, glargine-yfgn, has earned “interchangeable” status with brand-name Lantus. Interchangeable means your pharmacist can substitute it without needing a new prescription from your doctor, just like switching to a generic pill. Biosimilars generally cost less than their brand-name counterparts, which matters in a category of medication that many people take for decades.
How These Types Work Together
Most insulin regimens combine a basal insulin with a mealtime insulin. The basal component (long-acting or intermediate-acting) keeps your blood sugar steady in the background. The mealtime component (rapid-acting or short-acting) covers the surge that happens after eating. People with type 2 diabetes sometimes start with basal insulin alone and add mealtime doses later if needed, while people with type 1 diabetes almost always use both from the start.
The specific brands within each category can vary in onset, peak, and duration. Two rapid-acting insulins from different manufacturers won’t behave identically. Your response also depends on where you inject (the abdomen absorbs faster than the thigh), your activity level, and your body temperature. These variables are part of why managing insulin involves regular blood sugar monitoring and ongoing adjustments rather than a single fixed prescription.